High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site During Prevalent Delta Variant Period

Abstract

SARS-CoV-2 continues to develop new, increasingly infectious variants, such as delta and omicron. Here, we evaluate the efficacy of the Abbott BinaxNOW Rapid Antigen Test against the gold standard of Reverse Transcription Polymerase Chain Reaction (RT-PCR) in 1054 pediatric participants presenting to a state-owned high-volume Coronavirus Disease 2019 (COVID-19) testing site. During the testing period, the delta variant was predominant. Prior to sample collection, symptomatic and exposure status was collected for all participants based on Centers for Disease Control (CDC) criteria. RT-PCR results demonstrated an overall prevalence rate of 5.2%. For all participants, the sensitivity of the rapid antigen tests was 92.7% (95% CI 82.4% - 98.0%) and specificity was 98.0% (95% CI 97.0%-98.8%). For symptomatic participants, the sensitivity was 92.3% (95% CI 74.9% - 99.1%), specificity was 96.6% (95% CI 93.6%- 98.4%), positive predictive value (PPV) was 72.7% (95% CI 54.5% - 86.7%) and negative predictive value (NPV) was 99.2% (95% CI 98.2% - 100%). Among asymptomatic participants, the sensitivity was 92.6% (95% CI 75.7% - 99.1%), specificity was 98.6% (95% CI 97.5% - 99.3%) the PPV was 71.4% (95% CI 53.7% - 85.4%) and the NPV was 99.7% (95% CI 99.0% - 100%). Our reported sensitivity and NPV are higher than other pediatric studies, but specificity and PPV are lower. Importance Children are especially impacted by the disease and its ability to disrupt educational opportunities. Although vaccinations have been approved for children 5 years and older, many children remain unvaccinated. Widespread testing may improve the ability for children to remain in in-person activities, minimizing absences from school and extracurriculars. Highly accurate rapid antigen tests may be vital to containing future COVID-19 waves while mitigating detrimental effects.

Mathematical modeling for Delta and Omicron variant of SARS-CoV-2 transmission dynamics in Greece

“…The rate σ α is set at 1 to simplify the calculations. Studies reveal that antigen tests have significantly higher sensitivity (70–93%) in detecting the Delta variant compared to the Omicron variant (49–78%) ( Bayart et al., 2022 ; Bekliz et al., 2022 ; Cocherie et al., 2022 ; Sun et al., 2022 ). In the simulations, the highest sensitivity value of each variant is assumed.…”

“…(2021) p 25% proportion/probability of quarantined infected that cause secondary attack Krieg et al. (2022) l 93% (Delta) 78% (Omicron) sensitivity of self test diagnosis on asymptomatic individuals ( Bayart et al., 2022 ; Bekliz et al., 2022 ; Cocherie et al., 2022 ; Sun et al., 2022 ) …”